Literature DB >> 8183460

GM-2 gangliosidosis (Sandhoff's disease): two year follow-up by MRI.

W Koelfen1, M Freund, W Jaschke, S Koenig, C Schultze.   

Abstract

Two children with GM-2 gangliosidosis type 0 (Sandhoff's disease) followed up by MRI at 1.5 Tesla for 1.8 years are reported. One was presymptomatic at the first MRI examination. As her neurological status deteriorated, MRI showed low signal in bilaterally, on T2-weighted images the white matter with involvement of the optic radiations. In the second, MRI correlated well with the clinical progression of the disease, showing in the different stages involvement of thalamus and basal ganglia. There was no contrast enhancement and the grey matter remained normal.

Entities:  

Mesh:

Year:  1994        PMID: 8183460     DOI: 10.1007/bf00588086

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  18 in total

1.  MRI in the early stage of Tay-Sachs disease.

Authors:  H Yoshikawa; K Yamada; N Sakuragawa
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

Review 2.  Formation, maturation, and disorders of white matter.

Authors:  A J Barkovich; G Lyon; P Evrard
Journal:  AJNR Am J Neuroradiol       Date:  1992 Mar-Apr       Impact factor: 3.825

Review 3.  Disorders of lysosomes, peroxisomes, and mitochondria.

Authors:  B E Kendall
Journal:  AJNR Am J Neuroradiol       Date:  1992 Mar-Apr       Impact factor: 3.825

4.  Increased density of the thalamus on CT scans in patients with GM2 gangliosidoses.

Authors:  J Brismar; G Brismar; R Coates; G Gascon; P Ozand
Journal:  AJNR Am J Neuroradiol       Date:  1990 Jan-Feb       Impact factor: 3.825

5.  Late onset GM2-gangliosidosis. Clinical, pathological, and biochemical studies on 8 patients.

Authors:  E M Brett; R B Ellis; L Haas; J U Ikonne; B D Lake; A D Patrick; R Stephens
Journal:  Arch Dis Child       Date:  1973-10       Impact factor: 3.791

6.  Clinical course of GM2 gangliosidoses. A correlative attempt.

Authors:  F J Schulte
Journal:  Neuropediatrics       Date:  1984-09       Impact factor: 1.947

7.  The biochemical basis of gangliosidoses.

Authors:  K Sandhoff; E Conzelmann
Journal:  Neuropediatrics       Date:  1984-09       Impact factor: 1.947

8.  MR imaging of adrenoleukodystrophy.

Authors:  M Uchiyama; Y Hata; S Tada
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

9.  Dysmyelinating leukodystrophies: "LACK Proper Myelin".

Authors:  H P Hatten
Journal:  Pediatr Radiol       Date:  1991

10.  The value of computer axial tomography (CAT) in cranio-cerebral malformations.

Authors:  B E Kendall; D Kingsley
Journal:  Br J Radiol       Date:  1978-03       Impact factor: 3.039

View more
  14 in total

1.  MR brain imaging of fucosidosis type I.

Authors:  P Galluzzi; A Rufa; P Balestri; A Cerase; A Federico
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

2.  Characteristic MR spectroscopy in fucosidosis: in vitro investigation.

Authors:  Alex C Mamourian; Jeremy R Hopkin; Sanjeev Chawla; Harish Poptani
Journal:  Pediatr Radiol       Date:  2010-03-25

3.  Magnetic resonance imaging pattern recognition in hypomyelinating disorders.

Authors:  Marjan E Steenweg; Adeline Vanderver; Susan Blaser; Alberto Bizzi; Tom J de Koning; Grazia M S Mancini; Wessel N van Wieringen; Frederik Barkhof; Nicole I Wolf; Marjo S van der Knaap
Journal:  Brain       Date:  2010-10       Impact factor: 13.501

Review 4.  Decreased T2 signal in the thalami may be a sign of lysosomal storage disease.

Authors:  Taina Autti; Raimo Joensuu; Laura Aberg
Journal:  Neuroradiology       Date:  2007-03-03       Impact factor: 2.804

5.  Early changes in the apparent diffusion coefficient (ADC) in a mouse model of Sandhoff's disease occur prior to disease symptoms and behavioral deficits.

Authors:  Lingyun Hu; Yingying Sun; Laura E Villasana; Richard Paylor; Eric Klann; Robia G Pautler
Journal:  Magn Reson Med       Date:  2009-11       Impact factor: 4.668

Review 6.  Pediatric neurodegenerative white matter processes: leukodystrophies and beyond.

Authors:  Jonathan A Phelan; Lisa H Lowe; Charles M Glasier
Journal:  Pediatr Radiol       Date:  2008-04-30

7.  A case report of Sandhoff disease.

Authors:  R Saouab; M Mahi; R Abilkacem; H Boumdin; S Chaouir; O Agader; T Amil; A Hanine
Journal:  Clin Neuroradiol       Date:  2010-12-10       Impact factor: 3.649

8.  Serial MRI features of canine GM1 gangliosidosis: a possible imaging biomarker for diagnosis and progression of the disease.

Authors:  Daisuke Hasegawa; Osamu Yamato; Yuya Nakamoto; Tsuyoshi Ozawa; Akira Yabuki; Kazuhito Itamoto; Takayuki Kuwabara; Michio Fujita; Kimimasa Takahashi; Shunta Mizoguchi; Hiromitsu Orima
Journal:  ScientificWorldJournal       Date:  2012-03-12

9.  GM2-Gangliosidosis (Sandhoff and Tay Sachs disease): Diagnosis and Neuroimaging Findings (An Iranian Pediatric Case Series).

Authors:  Parvaneh Karimzadeh; Narjes Jafari; Habibeh Nejad Biglari; Sayena Jabbeh Dari; Farzad Ahmad Abadi; Mohammad-Reza Alaee; Hamid Nemati; Sasan Saket; Seyed Hasan Tonekaboni; Mohammad-Mahdi Taghdiri; Mohammad Ghofrani
Journal:  Iran J Child Neurol       Date:  2014

10.  Peripheral nervous system manifestations in a Sandhoff disease mouse model: nerve conduction, myelin structure, lipid analysis.

Authors:  Melanie A McNally; Rena C Baek; Robin L Avila; Thomas N Seyfried; Gary R Strichartz; Daniel A Kirschner
Journal:  J Negat Results Biomed       Date:  2007-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.